Added to YB: 2023-01-27
Pitch date: 2023-01-27
MTCR [bullish]
Metacrine, Inc.
+21.11%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Metacrine, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing therapies for patients with gastrointestinal diseases.
Market Cap
$25.5M
Pitch Price
$0.00
Price Target
N/A
Dividend
N/A
EV/EBITDA
0.38
P/E
-0.60
EV/Sales
N/A
Sector
Biotechnology
Category
N/A
Show full summary:
METACRINE INC MTCR
A summary for this pitch has not been created yet.
Read full article (0 min)